Evidence map›Paper›PMID 38665537›Full record

ArticleChemical science2024

Electrosynthesis of iminophosphoranes and applications in nickel catalysis.

Velabo Mdluli, Dan Lehnherr, Yu-Hong Lam, Mohammad T Chaudhry, Justin A Newman, Jimmy O DaSilva, Erik L Regalado

Open access · diamondAbstract read
In one paragraph

Article in Chemical science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Velabo MdluliProcess Research and Development, Merck & Co., Inc. Rahway New Jersey 07065 USA dan.lehnherr@merck.com.ORCID https://orcid.org/0000-0002-8536-6858
Dan LehnherrProcess Research and Development, Merck & Co., Inc. Rahway New Jersey 07065 USA dan.lehnherr@merck.com.ORCID https://orcid.org/0000-0001-8392-1208
Yu-Hong LamModeling and Informatics, Merck & Co., Inc. Rahway New Jersey 07065 USA yu.hong.lam@merck.com.ORCID https://orcid.org/0000-0002-4946-1487
Mohammad T ChaudhryAnalytical Research and Development, Merck & Co., Inc. Rahway New Jersey 07065 USA.ORCID https://orcid.org/0000-0002-1482-388X
Justin A NewmanAnalytical Research and Development, Merck & Co., Inc. Rahway New Jersey 07065 USA.ORCID https://orcid.org/0000-0002-2498-1259
Jimmy O DaSilvaAnalytical Research and Development, Merck & Co., Inc. Rahway New Jersey 07065 USA.ORCID https://orcid.org/0000-0001-7044-0640
Erik L RegaladoAnalytical Research and Development, Merck & Co., Inc. Rahway New Jersey 07065 USA.ORCID https://orcid.org/0000-0002-7352-6391
Merck & Co., Inc., Rahway, NJ, USA (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

P(v) iminophosphorane compounds are accessed

Identifiers

PMID38665537
PMCPMC11041257
OpenAlexW4392606150

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.